Legislators and policy makers could do a lot more to promote cancer research if they understood that improving treatment strategies is not all about new drugs, and that patients and health budgets pay a high [more]
«We must abandon the fiction that current oversight systems are adequate to protect volunteers in first-in-human trials or to steward scientific efforts»: this is the strong conclusion of a paper published in Nature by two [more]
It makes no sense to perform clinical research that has no relevance to patient care, so why do we do it, and how can we stop? John Ioannidis ponders the problem and offers some suggestions. [more]
The scientific complexity and economic cost of developing new cancer therapies demand a level of collaboration and sharing that takes both industry and academia well beyond their comfort zones. EORTC head Denis Lacombe believes he [more]
Jean-Yves Blay is leading efforts to reshape cancer research so that every trial has a translational element that can build knowledge about the mechanisms driving the disease. Download full article
Paolo Casali specialises in sarcoma, a rare’ cancer with at least 50 subgroups.Good practice, he believes, starts with a deep knowledge of the disease in front of you. This, in turn, requires a rigorous approach [more]
The European Union aims to become the most competitive and dynamic knowledge-based economy in the world. Why then does it put so many obstacles in the way of research? And why is a world-beating breast [more]
It took José Baselga just a few years to build the oncology department at Barcelona’s Vall d’Hebron hospital from a few shabby consulting rooms to a leading centre for research into targeted therapies. Europe has [more]
Just do it is a lesson Bruce Ponder learnt early in his research career, and it has stood him in good stead. He is now director designate of one of Europe’s largest cancer research centres, [more]
In 1972 Jean-Claude Horiot left a wonderful research job in the US to join a cancer centre in Dijon that was too small to conduct clinical trials on its own. He teamed up with similar [more]
Quack remedies’ have long been a thorn in the side of the medical establishment, but fear of ridicule means many patients don’t tell their doctors about any additional medicines they may be using. This problem [more]